Press Release – New York, NY – December 30, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of BiondVax …
Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $172.5 Million Upsized Public Offering Underwritten by Goldman Sachs and Jefferies
Press Release – New York, NY – December 14, 2021 – Sichenzia Ross Ference LLP today announced that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company …
Sichenzia Ross Ference LLP Represents Good Gaming, Inc. in $3.1 Million Private Placement Offering
Press Release – New York, NY – November 18, 2021 – Sichenzia Ross Ference LLP today announced that it represented Good Gaming, Inc., a gaming brand offering collaborative spaces for gamers and the …
Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to MAINZ BIOMED B.V. in $11.5 Million U.S. Initial Public Offering
Press Release – New York, NY – November 11, 2021 – Sichenzia Ross Ference LLP congratulates MAINZ BIOMED B.V. (the “Company”) (NASDAQ: MYNZ ), a molecular genetics diagnostic company specializing in …
Sichenzia Ross Ference LLP Represents VC-backed Cyngn, Inc. in $26.3 Million Initial Public Offering
Press Release – New York, NY – October 25, 2021 – Sichenzia Ross Ference LLP announced today that it represented Cyngn, Inc., (NASDAQ: CYN) a venture capital backed developer of innovative autonomous …
Sichenzia Ross Ference LLP Represents Parsec Capital Acquisition Corp. in $86.3 Million Initial Public Offering
Press Release – New York, NY – October 11, 2021 – Sichenzia Ross Ference LLP announced today that it represented Parsec Capital Acquisition Corp. (NASDAQ: PCXCU) in its initial public offering. …
